Institute of Clinical Medicine, KG Jebsen Centre for Psychosis Research, NORMENT: Norwegian Centre for Mental Disorders Research, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway; Division of Mental Health and Addiction, Oslo University Hospital, 0407 Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway; Division of Mental Health and Addiction, Oslo University Hospital, 0407 Oslo, Norway.
Schizophr Res. 2018 Mar;193:364-369. doi: 10.1016/j.schres.2017.07.006. Epub 2017 Jul 9.
Quality of life is an important outcome measure for patients with psychosis. We investigated whether going into stable symptomatic remission is associated with a more positive development of subjective quality of life (S-QoL) and if different patient characteristics are associated with S-QoL depending on remission status.
Three hundred and one patients with a first-episode psychosis were included at baseline. At 10-year follow-up 186 were reassessed. QoL was assessed by Lehman's Quality of Life Interview. Remission was defined according to criteria proposed by the Remission in Schizophrenia Working Group. One-way ANOVA, mixed model analysis, bivariate correlations and multiple regression analyses were performed.
Patients going into stable symptomatic remission showed a more positive S-QoL-development over the follow-up period and reported higher life satisfaction at 10-year follow-up compared to non-remission. At 10-year follow-up, depressive symptoms and alcohol abuse or dependence explained a significant amount of variance in S-QoL among patients in remission. Among patients in non-remission, PANSS excitative component explained a significant amount of variance in S-QoL. All significant effects were negative.
Stable symptomatic remission is associated with a more positive development of overall life satisfaction. Furthermore, different symptoms influence life satisfaction depending on status of remission. This has important clinical implications. While patients in remission might need treatment for depressive symptoms to increase S-QoL, in non-remission measures aiming to decrease hostility and uncooperativeness should be part of the treatment approach. Alcohol problems should be treated regardless of remission status.
生活质量是精神病患者的一个重要预后指标。我们调查了稳定的症状缓解是否与主观生活质量(S-QoL)的更积极发展有关,以及不同的患者特征是否与缓解状态有关的 S-QoL 有关。
在基线时纳入了 310 例首发精神病患者。在 10 年随访时,有 186 例被重新评估。使用 Lehman 的生活质量访谈评估生活质量。根据缓解精神分裂症工作组提出的标准定义缓解。进行了单因素方差分析、混合模型分析、双变量相关和多元回归分析。
进入稳定症状缓解的患者在随访期间表现出更积极的 S-QoL 发展,并报告在 10 年随访时的生活满意度更高。在 10 年随访时,抑郁症状和酒精滥用或依赖在缓解患者的 S-QoL 中解释了大量的方差。在非缓解患者中,PANSS 兴奋成分在 S-QoL 中解释了大量的方差。所有显著的影响都是负面的。
稳定的症状缓解与整体生活满意度的更积极发展有关。此外,不同的症状根据缓解状态影响生活满意度。这具有重要的临床意义。虽然缓解患者可能需要治疗抑郁症状来提高 S-QoL,但非缓解患者的治疗方法应旨在降低敌意和不合群性。无论缓解状态如何,都应治疗酒精问题。